Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
Overview
Study to learn if the alternate formulation is effective in agitated schizophrenic patients
Study Type
- Study Type: Interventional
- Study Design
- Primary Purpose: Treatment
- Study Primary Completion Date: January 2003
Interventions
- Drug: aripiprazole
Participating in This Clinical Trial
Inclusion Criteria
- Agitated schizophrenic patients
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.